Role of angiotensin II and endogenous vasodilators in the control of glomerular hemodynamics

Clinical and Experimental Nephrology

Volumn 7, Issue 3, 2003, Pages 172-178

  Arima, Shuji ^a  

^a TOHOKU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Afferent arteriole; Efferent arteriole; Glomerulus; Microperfusion

Indexed keywords

ANGIOTENSIN; ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN 2 RECEPTOR; NITRIC OXIDE; PROSTAGLANDIN; RECEPTOR SUBTYPE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERIOLE; ARTERY DIAMETER; ARTERY ENDOTHELIUM; BLOOD VESSEL TONE; CAPILLARY PRESSURE; CONTROLLED STUDY; ESSENTIAL HYPERTENSION; GLOMERULAR HEMODYNAMICS; GLOMERULUS; HEMODYNAMICS; HORMONAL REGULATION; HYPERTENSION; KIDNEY PERFUSION; KIDNEY VASCULAR RESISTANCE; NONHUMAN; PATHOPHYSIOLOGY; RAT; REVIEW; SPONTANEOUSLY HYPERTENSIVE RAT; VASCULAR RESISTANCE; VASOCONSTRICTION; VASODILATATION;

ANGIOTENSIN II; ANIMALS; HUMANS; KIDNEY GLOMERULUS; RENAL CIRCULATION; VASODILATION;

EID: 0141891972     PISSN: 13421751     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10157-003-0249-8     Document Type: Review

References (32)

1. Ichikawa I, Harris RC. Angiotensin action in the kidney: renewed insight into the old hormone, Kidney Int 1991;40:583-96.
2. Arendshorst WJ, Navar LG. Renal circulation and glomerular hemodynamics. In: Schreie R, editor. Diseases of the kidney, vol. 1. Boston: Little Brown; 1993. p. 65-117.
3. Edwards RM. Segmental effects of norepinephrine and angiotensin II on isolated renal microvessels. Am J Physiol 1983;244:F526-34.
4. Yuan BH, Robinette JB, Conger JD. Effect of angiotensin II and norepinephrine in isolated rat afferent and efferent arterioles. Am J Physiol 1990;258:F741-50.
5. Carmines PK, Morrison TK, Navar LG. Angiotensin II effects on microvascular diameters of in vitro blood-perfused juxtamedullary nephrons. Am J Physiol 1986;251:F610-18.
6. Steinhausen M, Sterzel RB, Fleming JT, Kuhn R, Weis S. Acute and chronic effects of angiotensin II on the vessels of split hydronephrotic kidney. Kidney Int 1987;31(Suppl 20):S64-73.
7. Ito S, Arima S, Ren YL, Juncos LA, Carretero OA. Endothelium-derived relaxing factor/nitric oxide modulates angiotensin II action in the isolated microperfused rabbit afferent but not efferent arteriole. J Clin Invest 1993;91:2012-9.
8. Arima S, Ren YL, Juncos LA, Carretero OA, Ito S. Glomerular prostaglandins modulate vascular reactivity of the downstream efferent arterioles. Kidney Int 1994;45:650-8.
9. Arima S, Endo Y, Yaoita H, Omata K, Ogawa S, Tsunoda K, et al. Possible role of P-450 metabolite of arachidonic acid in vasodilator mechanism of angiotensin II type 2 receptor in the isolated and microperfused rabbit afferent arteriole. J Clin Invest 1997; 100:2816-23.
10. Endo Y, Arima S, Yaoita H, Omata K, Tsunoda K, Takeuchi K, et al. Function of angiotensin II type 2 receptor in the postglomerular efferent arteriole. Kidney Int 1997;52(Suppl 53):S205-7.
11. Endo Y, Arima S, Yaoita H, Tsunoda K, Omata K, Ito S. Vasodilation mediated by angiotensin II type 2 receptor is impaired in afferent arterioles of young spontaneously hypertensive rats. J Vasc Res 1998;35:421-7.
12. Raij L, Shultz PJ. Endothelium-derived relaxing factor, nitric oxide: effects on and production by mesangial cells and the glomerulus. J Am Soc Nephrol 1993;3:1435-41.
13. Bonvalet JP, Pradelles P, Farman N. Segmental synthesis and actions of prostaglandins along the nephron. Am J Physiol 1987;253:F377-87.
14. Smith WL, Bell TG. Immunohistochemical localization of the prostaglandin-forming cyclooxygenase in renal cortex. Am J Physiol 1978;235:F451-7.
15. Dun MJ, Scharschmidt LA. Prostaglandins modulate the glomerular actions of angiotensin II. Kidney Int 1987;31(Suppl 20):S95-101.
16. Ardaillou N, Hagege J, Nivez MP, Ardaillou R, Schlondorff D. Vasoconstrictor-evoked prostaglandin synthesis in cultured human mesangial cells. Am J Physiol 1985;248:F240-6.
17. Baylis C, Brenner BM. Modulation by prostaglandin synthesis inhibitors of the action of exogenous angiotensin II on glomerular filtration in the rat. Circ Res 1978;43:889-98.
18. Arima S, Ito S, Omata K, Takeuchi K, Abe K. High glucose augments angiotensin II action by inhibiting NO synthesis in in vitro microperfused rabbit afferent arterioles. Kidney Int 1995;48:683-9.
19. Whitebread S, Mele M, Kamber B, DeGasparo M. Preliminary biochemical characterization of two angiotensin II receptor subtypes. Biochem Biophys Res Commun 1989;63:284-91.
20. Timmermans PBMWM, Wong PC, Chiu AT, Herblin WF, Benfield P, Carini DJ, et al. Angiotensin II receptors and angiotensin II receptor antagonists. Pharmacol Rev 1993;45:205-51.
21. Ichiki T, Labosky PA, Shiota C, Okuyama S, Imagawa Y, Fogo A, et al. Effects on blood pressure and exploratory behavior of mice lacking angiotensin II type-2 receptor. Nature 1995;377:748-50.
22. Hein L, Barsh GS, Pratt RE, Dzau VJ, Kobilka BK. Behavioral and cardiovascular effects of disrupting the angiotensin II type-2 receptor gene in mice. Nature 1995;377:744-7.
23. Kohagura K, Arima S, Endo Y, Chiba Y, Ito O, Abe M, et al. Involvement of cytochrome P450 metabolites in the vascular action of angiotensin II on the afferent arteriole. Hypertens Res 2001;24:551-63.
24. Siragy HM, Carey RM. The subtype-2 (AT2) angiotensin receptor regulates renal cyclic guanosine 3′,5′-monophosphate and AT1 receptor-mediated prostaglandin E2 production in conscious rats. J Clin Invest 1996;97:1978-82.
25. Siragy HM, Carey RM. The subtype 2 (AT2) angiotensin receptor mediates renal production of nitric oxide in conscious rats. J Clin Invest 1997;100:264-9.
26. Wilcox CS, Welch WJ, Murad F, Gross SS, Taylor G, Levi R, et al. Nitric oxide synthase in macula densa regulates glomerular capillary pressure. Proc Natl Acad Sci USA 1992;89:11993-7.
27. Mundel P, Bachmann S, Badr M, Fischer A, Kummer W, Mayer B, et al. Expression of nitric oxide synthase in kidney macula densa cell. Kidney Int 1992;42:1017-9.
28. Goto M, Mukoyama M, Suga S, Matsumoto T, Nakagawa M, Ishibashi R, et al. Growth-dependent induction of angiotensin II type 2 receptor in rat mesangial cells. Hypertension 1997;30:358-62.
29. Ma J, Nishimura H, Fogo A, Kon V, Inagami T, Ichikawa I. Accelerated fibrosis and collagen deposition develop in the renal interstitium of angiotensin type 2 receptor null mutant mice during ureteral obstruction. Kidney Int 1998;53:937-44.
30. Siragy HM, Carey RM. Protective role of the angiotensin AT2 receptor in a renal wrap hypertension model. Hypertension 1999;33:1237-42.
31. Siragy HM, Senbonmatsu T, Ichiki T, Inagami T, Carey M. Increased renal vasodilator prostanoids prevent hypertension in mice lacking the angiotensin subtype-2 receptor. J Clin Invest 1999;104:181-8.
32. Christen Y, Waeber B, Nussberger J, Porchet M, Borland RM, Lee RJ, et al. Oral administration of Dup 753, a specific angiotensin II receptor antagonist, to normal male volunteers. Inhibition of pressor response to exogenous angiotensin I and II. Circulation 1991;83:1333-42.